Use access key #2 to skip to page content.

MagicDiligence (< 20)

July 2013

Recs

1

Can Booz Allen (BAH) Continue Its Bull Run?

July 30, 2013 – Comments (0) | RELATED TICKERS: BAH , SAI , MANT

Booz Allen Hamilton (BAH) is yet another entry from one of Magic Formula® Investing's(MFI) favorite industry sectors - defense and government contractors. The stock is up nearly 30% over the past 3 months, riding the defense bull market along with several fellow MFI stocks like Northrop Grumman (NOC) (up 21%), Lockheed Martin (LMT) (also 21%), andExelis (XLS) (up an impressive 37%).  [more]

Recs

2

Magic Formula Investing Weekly Roundup 7/21/2013

July 21, 2013 – Comments (0) | RELATED TICKERS: CF , RPXC , GCI

Magic Formula Investing (MFI), as described by hedge fund manager Joel Greenblatt inThe Little Book that Beats the Market, consists of ranking stocks by earnings yield (cheap) and return on capital (quality), adding the rankings together, and buying from the resulting lists. Below are stocks that have moved into, and dropped out of, 3 of the MFI screens used by MagicDiligence:  [more]

Recs

1

Does ValueClick (VCLK) Live Up To Its Name?

July 16, 2013 – Comments (0) | RELATED TICKERS: CNVR , YHOO , GOOGL

advertising agencies. The company has 3 operating segments. The largest is the Media business (58% of sales, 52% of profits, 33% operating margin), which creates and provides tools to create Internet-only ad campaigns for its customers, and distributes the ads through search, e-mail, display ads, mobile, and a network of 18,500 web sites, reaching over 80% of all U.S. internet users, a reach second only to Yahoo! (YHOO).  [more]

Recs

1

A Myriad of Questions for MYGN

July 03, 2013 – Comments (0) | RELATED TICKERS: MYGN

Myriad Genetics (MYGN) is no stranger to adherents of Magic Formula® Investing(MFI). The stock has been in and out of the screens numerous times over the past 5 years, trading in a wide and volatile range despite delivering steady compound revenue growth of 23% and operating earnings growth of 28% over that period. In fact, I even recommended it as a MagicDiligence Top Buy pick in late 2010 and it was quite successful, appreciating 47% in 3 monthsbefore we sold it.  [more]

Recs

0

A Myriad of Questions for MYGN

July 03, 2013 – Comments (0) | RELATED TICKERS: MYGN

Myriad Genetics (MYGN) is no stranger to adherents of Magic Formula® Investing(MFI). The stock has been in and out of the screens numerous times over the past 5 years, trading in a wide and volatile range despite delivering steady compound revenue growth of 23% and operating earnings growth of 28% over that period. In fact, I even recommended it as a MagicDiligence Top Buy pick in late 2010 and it was quite successful, appreciating 47% in 3 monthsbefore we sold it.  [more]

Featured Broker Partners


Advertisement